AVE-5997
AVE-5997 is a selective b>D3 antagonist. AVE-5997 antagonizes MK-801 -induced hyperactivity. AVE-5997 can be used in the research of schizophrenia[1].
Product Specifications
CAS Number
452917-21-4
UNSPSC
12352005
Target
Dopamine Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C(NCCCCN1CCN(C2=CSC3=CC(C(F)(F)F)=CC=C32)CC1)NC4=CC=C(C)C=C4
Molecular Formula
C25H29F3N4OS
Molecular Weight
490.58
References & Citations
[1]Zhang M, et al. Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology. 2006 Jul;31 (7) :1382-92.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
D3 Receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
224644-01 50 µL
NSF (Vesicle-fusing ATPase, N-ethylmaleimide-Sensitive Fusion Protein, NEM-Sensitive Fusion Protein, Vesicular-Fusion Protein NSF) discontinued
Sign In for Pricing
View Details 224644-02 100 µL
NSF (Vesicle-fusing ATPase, N-ethylmaleimide-Sensitive Fusion Protein, NEM-Sensitive Fusion Protein, Vesicular-Fusion Protein NSF) discontinued
Sign In for Pricing
View Details 
038048-FITC 200 µL
M4A4A, NT (MS4A4A, 4SPAN1, CD20L1, MS4A4, Membrane-spanning 4-domains subfamily A member 4A, CD20 antigen-like 1, Four-span transmembrane protein 1) (FITC) discontinued
Sign In for Pricing
View Details